• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,260
3,567
3,455
2,871
2,806

COUNTRY

2,402
896
277
267
231

CATEGORIES

  • 950
  • 175
    • 41
    • 250
    • 49
  • 115
  • 294
    • 48
  • 504
  • 258
  • 241
  • 58
  • 59
  • 855
  • 1,504
  • 822
  • 20
  • 496
  • 1,422
  • 2,398
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 269
  • 32
  • 2,611
SHOW ALL…

PRICE

2,341
7,624
16,469
29,197

PUBLISHED

2,029
4,523
11,700
29,197

PRODUCT TYPE

26,257
1,059
1,041
524
163
58
24
21
21
16
6
6
1

Pharmaceuticals

(29,197 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Soft...

February 2015
FROM
Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Smoking...

February 2015
FROM
Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Ichthyosis...

February 2015
FROM
Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dyspnea. A key objective...

February 2015
FROM
Actinomycosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Actinomycosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Actinomycosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Actinomycosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Actinomycosis....

February 2015
FROM
Zollinger-Ellison Syndrome (Gastrinoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Zollinger-Ellison Syndrome (Gastrinoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Zollinger-Ellison Syndrome (Gastrinoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Zollinger-Ellison Syndrome (Gastrinoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Atopic...

February 2015
FROM
Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Asthma. A key objective...

February 2015
FROM
Bradycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Bradycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Bradycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Bradycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Bradycardia....

February 2015
FROM
Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Keratitis. A key...

February 2015
FROM
Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs...

February 2015
FROM
Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Endometriosis....

February 2015
FROM
Psychosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Psychosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Psychosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Psychosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Psychosis. A key...

February 2015
FROM
Proteinuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Proteinuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Proteinuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Proteinuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Proteinuria....

February 2015
FROM
Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Gingivitis. A...

February 2015
FROM
Gigantism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Gigantism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Gigantism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Gigantism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Gigantism. A key...

February 2015
FROM
Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Arthritis...

February 2015
FROM
Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Aplastic...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S